Boston Scientific

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

Boston Scientific

Mapping and Ablation
Transseptal Access Cardiac Ablation Solutions RF Cardiac Ablation Cardiac Mapping Cryo Cardiac Ablation Pulsed Field Ablation
Venous Therapies
EKOS Chronic Venous Obstruction Vein Treatment
Cardiac Rhythm Management
Structural Heart
TAVR Solutions Cerebral Embolic Protection Transseptal Access
Interventional Oncology
Drug-Eluting Technologies
Coronary

Playback speed

10 seconds

TheraSphere™ Y-90 Glass Microspheres: The DOSISPHERE-01 Trial

By Boston Scientific

190 views

February 17, 2021

The DOSISPHERE-01 Trial is a level I randomized trial that showed advanced HCC patients who ...
read more ↘ receive a personalized TheraSphere dose using multicompartment dosimetry had a median OS of 26.6 months– a 16-month improvement compared to the control arm.
↖ read less

Comments 0